It has been recognized over the past years that women form a distinct subpopulation within patients with coronary heart disease. This phenomenon should be acknowledged in the management and in the assessment of coronary heart disease. Over the past years remarkable progress has been made concerning our knowledge of cardiovascular risk factors related to gender. For instance, diabetes, high density lipoproteins and triglycerides levels have been found to have a greater impact on coronary heart disease risk in women compared to men. On the other hand, evidence showing that lipoprotein (a) is a cardiovascular risk factor seems to be stronger in men than in women. For optimal treatment and prevention of coronary heart disease it is necessary to acknowledge that it is not self-evident that women and men show simular responses to risk factors or to treatment. This review article addresses the role of cardiovascular risk factors focusing on the differential impact they might have on men and women. © 2002 Elsevier Science B. V. All rights reserved.
Introduction
both men and women [10, 11] , the impact of individual risk factors might be different. The influence of the menopause Traditionally, coronary heart disease (CHD) has been on both cardiovascular risk factors and CHD is unique for considered as a disease predominantly affecting men and women. Hence, women form a distinct subpopulation for a long time women were not included in cardiovascular within patients with CHD. This should be acknowledged in research programs. Although the life-time risk of CHD is the management and assessment of CHD. In the past years one in three for women [1] , they are still not fully aware of remarkable progress has been made concerning our knowltheir risk of CHD and perceive the chance of dying of edge of cardiovascular risk factors. In this review we breast cancer as far more likely than of CHD [2, 3] . In the discuss the role of cardiovascular risk factors focusing on early 1990s more attention was focused on women with the differential impact they have on men and women CHD. Since then an increasing number of studies have (Table 1) . been published concerning women's cardiovascular health. Several studies reported the existence of a gender difference in the use of diagnostic and therapeutic procedures 2. Epidemiology for CHD. Women were less likely to be referred for diagnostic and therapeutic procedures [4] [5] [6] . Also the CHD is the leading cause of death worldwide [12] . The prognosis for women with CHD was worse than for men lifetime risk of developing CHD at age 40 years is 50% for [7] [8] [9] . Although most risk factors contribute to CHD in men and 33% for women [1] . Over the past decades there seems to be a trend towards a decrease in cardiovascular mortality in North America and Western Europe [13] . Table 1 upregulating agents [26] . In the presence of low endogen- men and women [28, 29] . Recent studies included a suffi- as well as men to cholesterol lowering therapy [30] [31] [32] [33] .
Apo-B 111 111
The Scandinavian Simvastatin Survival Study (4S) showed Apo(a) 11 1(1) Smoking 11 11(1) that a reduction of high cholesterol level (range 5.5-8.0
Diabetes 11 111 mmol / l) in patients with CHD reduced major coronary events by 34% in both men and women [33] . In the average high-density lipoprotein cholesterol (HDL) levels was similar for men and women, although other reports (0.94 mmol / l for men and 1.03 mmol / l for women). This showed that mortality trends are more favorable in women study included 997 women (15% of the study population). than in men [15] [16] [17] [18] [19] . Controversy exists about the causes After a follow-up period of 5.2 years, the incidence of first of this decline in mortality. Several studies [13, 20] showed acute major coronary events was reduced by 37% in the no decline in the incidence of hospitalization for a first group who received lovastatin compared to those who myocardial infarction, suggesting an important contribureceived placebo. Although the beneficial effect of treating tion of improvement in medical treatment and secondary elevated levels of cholesterol and LDL in both genders is prevention of myocardial infarction. On the other hand, well established in secondary prevention, the use of lipid data from the World Health Organization Multinational lowering drugs in primary prevention will probably be Monitoring of Trends and Determinants in Cardiovascular reserved for high-risk patients for economic reasons. Disease (WHO MONICA) project indicate that the decline in case fatality of acute myocardial infarction can be 3.1.2. High-density lipoprotein cholesterol explained by an absolute reduction in the incidence of this High-density cholesterol (HDL) levels are reported to disease [16, 19] . This effect might be the result of primary correlate closely and inversely with the risk of CHD prevention and the modification of risk factors. [36] [37] [38] . HDL levels are higher in women than in men from young adulthood onwards [24, 39, 40] . Some studies [41, 42] , but not all [24, 25, 43] , have described a decrease in 3. Risk factors HDL levels following the menopause. The loss of protection from HDL is considered to be a major factor for the 3.1. Lipids increased coronary risk in postmenopausal women. It has been suggested that low levels of HDL are more predictive 3.1.1. Total cholesterol and low-density lipoprotein of coronary artery disease in women than in men [38] . cholesterol Because of the higher level of HDL in women, a modiTotal cholesterol and low-density lipoprotein cholesterol fication of the current National Cholesterol Education (LDL) levels in men and women are similar up to |20
Program (NCEP) guidelines has been proposed with more years of age [21] . In the third and fourth decades, aggressive targets for HDL in women [44] . Although it cholesterol levels increase more sharply in men than in was initially presumed that low HDL levels pose no risk in women [22] . Total cholesterol and LDL levels in women the absence of elevated LDL cholesterol, total cholesterol rise or even exceed the levels in men following the or elevated triglyceride levels, several studies have recentmenopause [23] [24] [25] . Estrogens are potent LDL receptorly shown that an 'isolated low HDL' level represents a significant risk of CHD [45] [46] [47] . The Veterans Affairs marker for functional reverse cholesterol transport than Cooperative Studies Program High-Density Lipoprotein HDL. Because HDL appears to be a less adequate predicCholesterol Intervention Trial (VA-HIT) showed that a tor for CHD for men than for women, apo A-I measuremodest increase in HDL levels in men with CHD and ment might be particularly valuable for men. This was normal LDL levels (#3.6 mmol / l) resulted in a significant supported by data from Kwiterovich et al. who found that reduction in the risk of major cardiovascular events [46] . the level of apo A-I but not the level of HDL was an So far, similar data for women are not available. In indicator of future CHD in 99 men and 104 women [59] . conclusion, the HDL level is an important factor affecting Atherogenic lipoproteins including LDL particles, very atherosclerosis. It might be appropriate to apply a gender low density lipoprotein (VLDL) particles, and remnants of specific approach in interpreting HDL levels because of the triglyceride-rich particles each contain one molecule of apo higher absolute levels and possible greater impact of HDL B [63] . Consequently, apo B gives an accurate estimation in women.
of the total number of atherogenic particles [64] . The composition of LDL particles, each containing one molecule of apo B, is heterogeneous because of the variable 3.1.3. Triglycerides content of cholesterol. Smaller and denser LDL particles Elevated levels of triglycerides have been associated are more atherogenic than larger, more buoyant ones with an increased risk of CHD in men and women [48, 49] . [65, 66] . Therefore, apo B could be superior compared to However, the role of plasma triglycerides as an indepen-LDL in determining CHD risk. This impression has been dent risk factor is still elusive. First, there are methodosupported by a number of studies in both women and men logical difficulties in interpreting triglyceride levels be- [59, 67, 68] . cause of high biologic intra-and inter-individual variFormer problems with measuring these apolipoproteins ability. Second, strong interactions exist between trihave been overcome with the standardization of apo A-I glycerides and other lipid factors. Elevated triglycerides and apo B [69, 70] . In conclusion, both apo A-1 and apo B are often seen with lower HDL levels and this combination might be better predictors for CHD in men and women and has been associated with increased CHD risk [50] . A may therefore be more suitable for cardiovascular risk meta-analysis including more than 46 000 men and nearly assessment than traditional lipid factors. 11 000 women showed for men and women, respectively, a 32 and 76% increase in cardiovascular risk associated with a 1-mmol / l increase in triglycerides. After adjustment 3.1.5. Lipoprotein(a) for HDL and other risk factors, these risks were decreased Lipoprotein(a) consists of an LDL particle bound by a to 14% in men and 37% in women, but this remained disulfide bridge to apolipoprotein(a) that has a structure statistically significant for both genders [51] . It seems that resembling plasminogen. Lipoprotein(a) levels are indepenelevated triglycerides increase cardiovascular risk more in dent of other lipid parameters [71] . In women, circulating women than in men, implying a gender difference in the lipoprotein(a) levels increase after the menopause just like role of triglycerides in atherosclerosis [52] . Therefore, the other lipid parameters (triglycerides, LDL and total analogous to the gender-specific approach for HDL, the cholesterol) [72] . latest NCEP guidelines have suggested that that the Most cross-sectional, case-control studies and prospecoptimal levels for triglycerides may be lower for women tive studies show that lipoprotein(a) is a risk factor for [44] . There is accumulating evidence that postprandial CHD. Prospective studies have reported that elevated triglyceride levels are of major importance in determining levels of lipoprotein(a) (in particular of lipoprotein(a) cardiovascular risk [53] [54] [55] and that premenopausal levels of .0.30 g / l) are associated with an increase in women have lower triglyceride levels than men and CHD even after adjustment for other cardiovascular risk postmenopausal women [56] [57] [58] .
factors in men [73] [74] [75] and in women [73, 76] . Other data indicate that lipoprotein(a) is not as strong a risk factor for CHD in women as in men [77, 78] The results of these 3.1.4. Apolipoproteins A-I and B studies might have been biased because of the low CHD Apolipoprotein A-I (apo A-I) is the major apolipoprotein event rate in women. Elevated lipoprotein(a) levels are of HDL. Apo A-I has previously been reported to be a difficult to treat. The only drugs that lower lipoprotein(a) better marker for CHD than HDL [59] [60] [61] . Biologically, levels are nicotinic acid, and, as recently shown, hormone this finding is plausible because not all HDL particles are replacement therapy (HRT) [79] . The reports on the effect equal in size. Two subclasses of HDL can be recognized, of fibrate therapy on the synthesis of lipoprotein(a) are HDL particles that only contain apo A-I, lipoprotein A-I, conflicting [80] [81] [82] . In conclusion, lipoprotein(a) can be and particles that contain both apo A-I and apo A-II, regarded as a cardiovascular risk factor, but the evidence in lipoprotein A-I /A-II. In general, lipoprotein A-I is considwomen is not as strong as in men. More data are necessary ered to be more protective against CHD than lipoprotein to determine whether gender-related differences are clini-AI /A-II [62] . Therefore, apo A-I levels may be a better cally relevant.
3.2. Smoking ceptives, elderly individuals and persons with isolated hypertension [105] . However, with the large number of Smoking is the most important preventable cause for the persons who are now considered for anti-hypertensive development of CHD among men and women [83] . In the treatment, risk stratification is necessary for this treatment United States 23.9% of women and 27.3% of men older to remain cost-effective. In conclusion, hypertension is a than 18 years are current smokers [84] . A clear dosehighly prevalent risk factor, especially in the elderly. response relationship exists between the number of cigaretBecause of the tendency of risk factor clustering in the tes smoked and the increase of risk of CHD [85, 86] .
presence of elevated blood pressure, hypertension is an Fortunately, smoking cessation can considerably reduce important marker for patients with a high-risk profile. The the risk of CHD in both genders [87, 88] . After 2-3 years current guidelines for the treatment of hypertension have of abstinence the level of risk of ex-smokers is similar to incorporated this view and emphasize risk factor interventhat of never smokers regardless of the amount or duration tion [105, 106] . of cigarettes smoked or the age at which they stopped smoking [87] . This beneficial effect is sustained at an older 3.4. Diabetes age [89, 90] . A number of studies [10, 85, 91] showed that smoking appears to be a stronger risk factor for myocardial Diabetes is a powerful risk factor for CHD. Up to infarction in middle-aged women than in men. Smoking 75-80% of adult diabetic patients die of cardiovascular has also been associated with an early menopause [92] [93] [94] .
diseases, and 75% of these deaths are caused by CHD A recent study showed that current smoking decreased the [107] . Compared to diabetic men, who have a two-fold to age of the natural menopause by 2 years and past smoking three-fold increased risk of CHD, diabetic women are by 1 year [94] . In both men and women smoking has an reported to have a three-fold to seven-fold increased risk unfavorable affect on plasma lipoproteins, in particular a [108] [109] [110] [111] . Thus, diabetes seems to eliminate the predecrease in HDL [10, 91, 95] . Some studies have suggested menopausal 'female advantage' in the prevalence of CHD that this harmful effect on HDL is more pronounced in [112] . Mortality from myocardial infarction is significantly female smokers than in male smokers [10, 95] . In concluhigher in diabetic women than in non-diabetic women and sion, smoking is a very important modifiable risk factor in men with or without diabetes [113] . Lipid abnormalities that seems to have at least a similar impact in women and frequently found in patients with diabetes type II are men. elevated triglycerides, low HDL levels and small dense LDL [114] . Goldschmidt et al. [108] showed that de-3.3. Hypertension creased HDL and very low-density lipoprotein levels predict CHD mortality in diabetic women but not in Elevated systolic blood pressure is, as risk factor, at non-diabetic women or diabetic and non-diabetic men. least as powerful as diastolic blood pressure [96, 97] .
Because of the poor prognosis for women with diabetes, Isolated systolic hypertension, defined as a systolic blood aggressive treatment of cardiovascular risk factors, such as pressure $160 mmHg and a diastolic blood pressure ,90 dyslipidemia, should be a high priority. mmHg [98] , is associated with an increased risk of cardiovascular disease, stroke and all-cause mortality in 3.5. Obesity men and women independent of other risk factors [99, 100] . Isolated systolic hypertension is an indication of loss of Obesity is an independent risk factor for CHD in women arterial elasticity, and its prevalence increases with age for as well as in men [115, 116] . Willet and colleagues [115] both sexes [101] . However, the rise in prevalence of showed in data from the Nurses' Health Study that even isolated systolic hypertension is steeper for women than women with a modestly increased body mass index (.25   2 for men $55 years of age [102] . Isolated systolic hypertenand ,29 kg / m ) had twice the risk of CHD as the leanest 2 sion is a common finding in elderly women, with a women (body mass index ,21 kg / m ). Independent of prevalence of 30% in women over 65 years of age [103] .
overall obesity, the distribution of body fat is a deterThe Systolic Hypertension in the Elderly Program (SHEP) minant of cardiovascular risk. It has been shown that [98] has shown that both men and women with isolated truncal obesity, the so-called android habitus, confers a far systolic hypertension benefit from blood pressure control.
higher risk than the peripheral or 'gynecoid' body fat Antihypertensive treatment reduced the incidence of stroke distribution [117] [118] [119] . Waist-hip ratio and waist circumand non-fatal myocardial infarction (36 and 27%, respecference are highly correlated to the risk of CHD [117] . tively). Large long-term clinical trials have included both
Rexrode and colleagues showed that women with a waistmen and women and a meta-analysis of these studies did hip ratio of 0.76 or higher or waist circumference of $76.2 not show significant gender differences in blood pressure cm had a markedly increased cardiovascular risk even after and clinical outcome [104] . The current guidelines recomadjustment for hypertension, diabetes and elevated cholesmend antihypertensive therapy for a heterogeneous populaterol levels [117] . Weight reduction was associated with an tion including pregnant women or women on oral contraimprovement in risk factors and favorable changes in triglycerides, high and low-density lipoprotein levels and 3.7. Homocysteine blood pressure [120, 121] . These observations suggest a beneficial effect of weight reduction, but direct evidence Over the past 10 years many studies have demonstrated that weight loss reduces the risk of CHD is currently not a relationship between elevated levels of total plasma available. Because of the difficulty of achieving and homocysteine and increased risk of CHD [130] . For a long maintaining weight loss, the prevention of obesity is of time data in women were scarce. When women were utmost importance. included, they often formed a small percentage of the population. In addition, in most cases estimations of 3.6. Family history vascular disease risk were given for the pooled sexes [131] . Several studies that did include women have shown Familial aggregation of CHD has been studied in both that the risk of vascular disease associated with elevated women and men [122] [123] [124] . Research on family history as homocysteine levels was at least as strong in women as in a cardiovascular risk factor is complicated by methodomen [131] [132] [133] [134] . Meta-analysis showed that the summary logical factors such as identification and the definition of a odds ratio, based on a 5-mmol / l increment in plasma positive family history and endpoints. These factors can homocysteine, was 1.6 for men and 1.8 for women [134] . act as confounding elements in comparing study results.
Homocysteine levels rise with age, and fasting homoAlso, the interaction between known risk factors and cysteine levels appear to be generally lower in women than family history is evident. Therefore, the underlying mechain men [131] . Higher homocysteine levels in men might be nism of how family history acts as a risk factor and the due to both their larger muscle mass since most plasma separate impact of genetic and environmental factors is homocysteine is formed in conjunction with creatinestill controversial. Several studies showed that a parental creatinine synthesis. Furthermore, a homocysteine-lowerhistory of CHD increases the chance of premature onset of ing effect of estrogens has been reported in some studies CHD in men [125] . As with most risk factors, results in [135, 136] . This latter mechanism might also explain why women became available much later. An early study some studies found that the levels of homocysteine in showed that an independent effect on cardiovascular death postmenopausal women were higher than in premenopauswas only present in men of ,60 years but not in women al women and even men of a similar age [137, 138] . It has [126] . This study, however did not include a sufficient been suggested that the lower levels of homocysteine in enough number of women to detect a significant relationpremenopausal women contribute to the lower incidence of ship between family history and risk of CHD. More recent vascular disease [139] . However, controversy still exists as studies have reported that a family history of CHD is also to whether elevated homocysteine is a cause or a consea risk factor for women [122] [123] [124] 127, 128] . The Nurses' quence of CHD. The majority of prospective studies in Health Study showed an age-adjusted risk of non-fatal individuals initially free of CHD failed to show a signifi-CHD of 2.8 and an age-adjusted risk of fatal CHD of 5.0 cant association between elevated homocysteine and CHD in women with a parental history of myocardial infarction incidence [140] . On the other hand, recent evidence before 60 years of age [127] . Recently, some studies suggests that hyperhomocysteinemia is an independent risk showed that the risk of premature CHD was higher in factor for arterial endothelial dysfunction and might therewomen compared to men [122, 124, 129] . A Finnish study fore act as pathogenic factor in the development of showed that 76% of the women and 62% of the men who vascular disease [141] . survived a myocardial infarction had first degree relatives with CHD at ,65 years of age. In particular, the sisters of 3.8. Fibrinogen female patients were at risk for CHD [124] . Jousilahti et al. [122] showed that the adjusted risk of a first coronary
The haemostatic system plays an important role in the event was markedly higher for women than for men pathogenesis of atherosclerosis. Several studies have dem-(relative risk 2.64 vs. 1.64, respectively). However, the onstrated a significant association of fibrinogen level and practical implications of identifying a positive family cardiovascular disease in men and women [142] [143] [144] . history as a risk factor are uncertain. At this moment the Plasma fibrinogen levels are higher in women and increase only application is identifying individuals who are at risk.
with smoking, age, post-menopausal status, obesity and In the future genetic research may be able to identify use of oral contraceptives [145] [146] [147] . Smoking cessation, different subtypes in the familial risk and this could be alcohol use and weight loss have a lowering effect on used for targeted counseling and therapy to prevent CHD.
fibinogen levels [145, 146] . In the Framingham study, the In conclusion, women and men with a positive family risk for CHD associated with fibrinogen diminished with history have an increased risk of premature coronary age in women but not in men [148] . After the menopause, events. Recent results indicated that this risk might be levels of fibrinogen increase, but as antithrombotic factors higher in women compared to men. To date, neither the like antithrombin III and plasminogen increase, the net evaluation nor the interpretation of family history as a risk effect of the menopause is unclear [149] . Several drugs factor for CHD are completely established.
including fibrates, propranolol, nislodipine and ticlopidine [150] and HRT have been reported to lower fibinogen 3.11. Psychosocial factors levels [151] . In conclusion, fibrinogen is an important cardiovascular risk factor that can be modified by external Psychosocial factors such as socio-economic status and factors (e.g. drug therapy), life style and the female social support have been frequently linked to CHD in both hormonal status.
men and women [169] [170] [171] [172] . Although initially data for women were scarce and inconclusive, several studies have addressed the role of psychosocial issues for women 3.9. Infections [169, 172, 173] . A low education level has been associated with an increased incidence of CHD, mainly because of the The possible role of chronic infections and CHD has strong inverse correlation of atherogenic risk factors and been investigated in a number of studies. Most of these education attainment. It is a consistent finding that men studies relate to Helicobacter pylori and Chlamydia pneuand women with lower education have a higher incidence moniae. A great number of studies found evidence for an of elevated blood pressure, total cholesterol, body mass association between C. pneumoniae antibodies and CHD index and current smoking [174] [175] [176] . The psychosocial [152] . More recently, C. pneumoniae studies have been work environment also seems predictive for future CHD. published both supporting [153, 154] and refuting [155- The Whitehall II study showed that men and women with 157] its role in the pathogenesis of CHD. Most of these low job control, either self-reported or independently studies have only included men or did not consider women assessed, had a higher risk of newly diagnosed CHD [177] . separately. Two studies carried out a separate analysis for Subjects with low job control had an odds ratio for any men and women. One study found a possible association subsequent coronary event of 1.93 compared to subjects between circulating C. pneumoniae DNA and CHD in men with high job control. This association could not be only [153] . The other study found that serological evidence explained by employment grade or classic coronary risk of an C. pneumoniae infection was associated with an factors [177] . In conclusion, these findings support the atherogenic lipid profile in men but not in women [158] .
significance of psychosocial factors for CHD for both men However, because of the relatively small number of and women. women included, these results might be coincidental and lack statistical power. Therefore, further research is needed 3.12. Estrogens to investigate these associations. Of the five prospective studies [159] [160] [161] [162] [163] which examined whether H. pylori was Unique to women is the influence of their hormonal associated with cardiovascular disease, three studies status on CHD. In comparison with men of a similar age [159, 161, 163] included women. None of these prospective and postmenopausal women, the incidence of CHD is studies found any statistically significant evidence for a significantly lower in premenopausal women suggesting relationship between CHD and H. pylori infection. In that endogenous estrogens have a protective effect on the summary, data are not available to show that infective development of CHD [94, 178, 179] . Estrogens affect the agents are of major importance as risk factors for CHD in atherosclerotic process through a variety of mechanisms. either men or women.
Estrogens have been reported to have a lowering effect on total cholesterol and LDL [23, 25, 180] [166] atheroprotective effect involving inhibition of smooth-musmen. Recently, the predictive value of CRP has been cle cell proliferation [186] . The role of exogenous esinvestigated in middle-aged and elderly women [166, 167] .
trogens is controversial. Meta-analyses of multiple obInterestingly, both studies found that the relative risks servational studies suggested a 35-50% reduction of CHD associated with CRP were higher for women than for men.
associated with the use of estrogens after the menopause It remains to be investigated whether these results reflect [187] . However, two double blind randomized trials true sex differences or whether they are chance. In a recent [181, 184] addressing this topic both failed to demonstrate study, Ridker et al. [168] raised the possibility of adding a favorable effect of HRT for the secondary prevention of CRP measurements to the standard lipid screening, since CHD. The Hormone Estrogen Replacement Study (HERS) CRP was the most significant and strongest risk factor for [184] , which compared HRT consisting of estrogen plus cardiovascular events in healthy middle-aged women progestin with placebo in women with CHD showed no compared to measurements of homocysteine, lipids and overall benefit of HRT on coronary death and non-fatal apolipoproteins. In conclusion, evidence of the importance myocardial infarction, despite an 11% decrease in LDL of CRP as marker for future CHD is becoming more and a 10% increase in HDL. Moreover, an increase was convincing for women.
seen in the relative risk of venous thrombotic events and gallbladder disease of 2.89 and 1.38, respectively. Interestthat risk factors such as smoking, family history and ingly, a time trend was seen with more coronary events in inflammation characterized as C-reactive protein, have a the 1st year with HRT, and fewer in years 4 and 5.
more negative influence on CHD in women than in men. Therefore, the HERS investigators recommended not On the other hand the evidence showing that lipoprotein(a) initiating this hormone regiment for secondary prevention is a cardiovascular risk factor seems to be stronger in men of CHD, but given the late benefit of long-term use, it than in women. The majority of cardiovascular risk factors could be appropriate to continue HRT for women who show no important differences between the genders. For already use this therapy. Recently a double-blind placebo optimal treatment and prevention of CHD it is necessary to controlled trial examined the effect of estrogen, estrogen acknowledge that it is not self-evident that women and with progesterone or placebo on the progression of cormen show a similar response to risk factors or to treatment. onary atherosclerosis in women with CHD [181] . No effect Therefore, it is essential that studies present results accordwas found for estrogen alone or estrogen in combination ing to gender, in order to comprehend to what extent CHD with progesterone on the progression of coronary atheroprevention measures are similar for men and women. sclerosis. Despite these landmark studies, many issues concerning hormone use in postmenopausal women are still unresolved. Estrogen therapy might be more protective References in preventing atherosclerosis than in slowing down the progression of established disease. No data for estrogen [ ifen had a favorable effect on cardiovascular risk by women, with a scheduled follow-up period of |5 years A statewide study. MIDAS Study Group. Myocardial Infarction [190] . In conclusion, at this time the benefit of exogenous Data Acquisition System. Circulation 1994; 90:1715-1730. estrogens for the prevention of CHD is unconvincing. ences between men and women. Except for female hor- 
